Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03150381
Other study ID # X120329018
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 1, 2012
Est. completion date March 31, 2018

Study information

Verified date May 2018
Source University of Alabama at Birmingham
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study tests evidence-based strategies for weight loss among overweight and obesity cancer survivors and family members in rural Alabama.


Description:

This is a 3-arm cluster randomized controlled study that compares a trained lay provided weight loss program vs. the same program plus community-based weight management strategies vs. general cancer prevention education on weight loss and other clinical outcomes (primary outcomes) and healthy behaviors, and psychosocial functioning (secondary outcomes).


Recruitment information / eligibility

Status Completed
Enrollment 369
Est. completion date March 31, 2018
Est. primary completion date March 31, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 19 Years and older
Eligibility Inclusion Criteria:

- African American breast, colon, or prostate cancer survivor (Index Participant)

- Family member (support person) of African American breast, colon, or prostate cancer survivor (Family Member Participant)

- Live, work, or attend school in target county

- BMI >= 25 kg/m2

Exclusion Criteria:

- Pregnant or planning to become pregnant in the next year

- Known major medical or psychological condition known to influence body weight

- Uncontrolled hypertension (BP > 160 mmHg systolic or >100 mmHg diastolic)

- medicated or poorly controlled diabetes (glucose > 126) Cardiovascular event in the preceding 12 months

- History of gastric bypass or bariatric surgery

- History of psychiatric hospitalization in past 2 years

- History of substance abuse or eating disorder

- Any other condition by which a medical professional has suggested diet modification, physical activity and/or weight reduction would be contraindicated

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Weight Loss Only
24- month weight loss program (year 1: weekly in person meetings for 6 months, followed by 2 meetings per month for 3 months, then monthly for 3 months; year 2: monthly phone calls)
Weight Loss Plus
Participants will attend in-person weekly sessions (about 1.5 hours each) for 6 months and then twice a month for 3 months and monthly for 3 months. Sessions focus on behavioral techniques supporting healthy diet (including calorie restriction for weight loss) and achieving recommended amounts of physical activity per week. During 1-year weight loss maintenance, participants receive monthly motivational phone calls.
Control
Participants receive quarterly newsletters containing generic cancer prevention messages and participate in community-wide cancer awareness educational sessions.

Locations

Country Name City State
United States University of Alabama at Birmingham Birmingham Alabama

Sponsors (1)

Lead Sponsor Collaborator
University of Alabama at Birmingham

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Weight Measured weight (nearest kg) Baseline to 6 months
Secondary Waist Circumference Measured circumference (nearest cm) Baseline to 24 months
Secondary Lipids Measured total cholesterol, triglycerides, HDL, LDL, ratio (mg/dL) Baseline to 24 months
Secondary Blood Pressure Measured blood pressure (mmHG) - systolic and diastolic Baseline to 24 months
Secondary Weight Measured weight (nearest kg) Baseline to 12 months
Secondary Weight Measured weight (nearest kg) Baseline to 24 months
Secondary Social Support for Diet and Exercise Behaviors self report measure of social support (family, friend) in performing diet and exercise behaviors Baseline to 6 months
Secondary Social Support for Diet and Exercise Behaviors self report measure of social support (family, friend) in performing diet and exercise behaviors Baseline to 12 months
Secondary Social Support for Diet and Exercise Behaviors self report measure of social support (family, friend) in performing diet and exercise behaviors Baseline to 24 months
Secondary Self Efficacy for Diet and Exercise Behaviors self report measure of confidence in performing diet and exercise behaviors Baseline to 6 months
Secondary Self Efficacy for Diet and Exercise Behaviors self report measure of confidence in performing diet and exercise behaviors Baseline to 12 months
Secondary Self Efficacy for Diet and Exercise Behaviors self report measure of confidence in performing diet and exercise behaviors Baseline to 24 months
Secondary Automated Self-Administered 24-Hour Dietary Assessment Tool (ASA24) self report measure of dietary intake Baseline to 6 months
Secondary Automated Self-Administered 24-Hour Dietary Assessment Tool (ASA24) self report measure of dietary intake Baseline to 12 months
Secondary Automated Self-Administered 24-Hour Dietary Assessment Tool (ASA24) self report measure of dietary intake Baseline to 24 months
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases